Abstract
Bladder pain syndrome/interstitial cystitis (BPS/IC) represents a major health burden in the United States and around the world. A recent study (RAND Interstitial Cystitis Epidemiology) estimated that 6.5 % of American women suffer from the disease [1]. Women who were younger or college-educated had greater symptom persistence [2]. Treatment options are broad, from behavioral modification, to oral pharmacologic agents, to intravesical treatments. Intravesical therapy is popular because it spares patients from the systemic effects of oral agents. In this regard, intravesical Dimethyl sulfoxide (DMSO) has been used for many years by urologists in managing these challenging patients.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Berry SH, Elliott MN, Suttorp M, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540–4. doi:10.1016/j.juro.2011.03.132.
Suskind AM, Berry SH, Suttorp MJ, Elliott MN, Clemens JQ. Symptom persistence in a community cohort of women with interstitial cystitis/bladder pain syndrome (IC/BPS): 3-, 6-, 9-, and 12-month follow-up from the RICE cohort. Int Urogynecol J. 2014;25(12):1639–43. doi:10.1007/s00192-014-2420-z.
Shirley SW, Stewart BH, Mirelman S. DMSO background literature. http://www.dmso.org/articles/bladder/bladder1.htm. Accessed 3 Jun 2015.
Perez-Marrero R, Emerson LE, Feltis J. A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol. 1988;140(1):36–9.
Peeker R, Haghsheno M-A, Holmäng S, Fall M. Intravesical bacillus calmette-guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study. J Urol. 2000;164(6):1912–6.
Hanno PM, Burks DA, Clemens JQ, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162–70. doi:10.1016/j.juro.2011.03.064.
Ferguson DR, Kennedy I, Burton TJ. ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes–possible sensory mechanism? J Physiol. 1997;505(2):503–11.
Sun YAN, KEAY S, De DEYNEPG, CHAI TC. Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis. J Urol. 2001;166(5):1951–6.
Sun Y, Chai TC. Effects of dimethyl sulphoxide and heparin on stretch-activated ATP release by bladder urothelial cells from patients with interstitial cystitis. BJU Int. 2002;90(4):381–5.
Melchior D, Packer CS, Johnson TC, Kaefer M. Dimethyl sulfoxide: does it change the functional properties of the bladder wall? J Urol. 2003;170(1):253–8. doi:10.1097/01.ju.0000071520.73686.3d.
Shiga KI, Hirano K, Nishimura J, Niiro N, Naito S, Kanaide H. Dimethyl sulphoxide relaxes rabbit detrusor muscle by decreasing the Ca2+ sensitivity of the contractile apparatus. Br J Pharmacol. 2007;151(7):1014–24.
Kim R, Liu W, Chen X, Kreder KJ, Luo Y. Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models. J Biomed Biotechnol. 2011;2011:1–9. doi:10.1155/2011/937061.
Soler R, Bruschini H, Truzzzi J, et al. Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of non-bacterial cystitis. Int Braz J Urol. 2008;34(4):503–11.
Stout L, Gerspach JM, Levy SM, et al. Dimethyl sulfoxide does not trigger urine histamine release in interstitial cystitis. Urology. 1995;46(5):653–6.
Colaco MA, Evans RJ. Current recommendations for bladder instillation therapy in the treatment of interstitial cystitis/bladder pain syndrome. Curr Urol Rep. 2013;14(5):442–7. doi:10.1007/s11934-013-0369-y.
Parkin J, Shea C, Sant G. Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis – a practical approach. Urology. 1997;49 Suppl 5:105–7.
Biggers RD. Self-administration of dimethyl sulfoxide (DMSO) for interstitial cystitis. Urology. 1986;28(1):10–1.
Rössberger J, Fall M, Peeker R. Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis discomfort, side-effects and treatment outcome. Scand J Urol Nephrol. 2005;39(1):73–7. doi:10.1080/00365590410018738.
Ghoniem GM, McBride D, Sood OP, Lewis V. Clinical experience with multiagent intravesical therapy in interstitial cystitis patients unresponsive to single-agent therapy. World J Urol. 1993;11(3):178–82.
Smith KJ, Chess-Williams R, McDermott C. Luminal DMSO: effects on detrusor and urothelial/lamina propria function. BioMed Res Int. 2014;2014:1–8. doi:10.1155/2014/347616.
Hung M-J, Chen Y-T, Shen P-S, Hsu S-T, Chen G-D, Ho ES-C. Risk factors that affect the treatment of interstitial cystitis using intravesical therapy with a dimethyl sulfoxide cocktail. Int Urogynecol J. 2012;23(11):1533–9. doi:10.1007/s00192-012-1699-x.
Domingue G, Ghoniem G, Bost KL, Fermin C, Human LG. Dormant microbes in interstitial cystitis. J Urol. 1995;153:1321–6.
Stewart B, Branson A, Hewitt C, Kiser W, Straffon R. The treatment of patients with interstitial cystitis, wiht special reference to intravesical DMSO. J Urol. 1972;107(3):377–80.
Stewart B, Shirley S. Further experience with intravesical dimethyl sulfoxide in the treatment of interstitial cystitis. J Urol. 1976;116:36–8.
Fowler J. Prospective study of intravesical dimethyl sulfoxide in treatment of suspected early interstitial cystitis. Urology. 1981;18(1):21–6.
Dawson TE, Jamison J. Intravesical treatments for painful bladder syndrome/interstitial cystitis. Cochrane Libr. 2007;4:CD006113. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006113.pub2/full. Accessed 5 Apr 2015.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Moskowitz, D., Ghoniem, G. (2017). Intravesical Therapy for Bladder Pain Syndrome/Interstitial Cystitis: Dimethyl Sulfoxide. In: Moldwin, R. (eds) Urological and Gynaecological Chronic Pelvic Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-48464-8_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-48464-8_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-48462-4
Online ISBN: 978-3-319-48464-8
eBook Packages: MedicineMedicine (R0)